T-VEC in Non-melanoma Skin Cancer

    Not Recruiting
  • participants needed
  • sponsor
    University of Zurich
Updated on 22 January 2021
melanoma skin
skin cancer
squamous cell carcinoma
non-melanoma skin cancer
carcinoma of skin
merkel cell carcinoma
advanced squamous cell carcinoma


Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) in patients with locally advanced non-melanoma skin cancer.


This study evaluates the administration of T-VEC in non-melanoma skin cancer. The aim is to evaluate the effectiveness, safety and tolerability of T-VEC in patients with non-melanoma skin cancer through determination of local immune effects after repeated T-VEC injections.

Condition Basal cell carcinoma, Squamous cell carcinoma, Merkel cell carcinoma, Cutaneous Lymphoma, Non-melanoma Skin Cancer, Non-melanoma Skin Cancer
Treatment Talimogene Laherparepvec (T-VEC)
Clinical Study IdentifierNCT03458117
SponsorUniversity of Zurich
Last Modified on22 January 2021

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note